chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient complaining of faster heart rate waiting post vaccination. Patient given privacy, legs elevated, ice pack placed on his back, water given. Patient has a history of anxiety and panic attacks. Patient stated event felt "exactly like a panic attack." Patient assessed and educated by on-site Nurse Practitioner and advised to seek medical attention if needed. Patient waited 30 minutes, symptoms resolved. Patient verbalized they were, "feeling much better."
DIZZY, TINNITIS, SYNCOPE, EMESIS, SEEN BY PARAMEDICS, PROVIDED GATORADE AND SNACK, SYMPTOMS IMPROVED, REFUSED TRANSPORT, AMA SIGNED.
I tested positive for Covid-19 on March 21, 2023, I experienced slight fever, airway blockage; phlegm; sore throat, shortness of breath, I was using cough suppressant; TYLENOL, ibuprofen, and PAXLOVID for my symptoms.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with a dose PNEUMOVAX 23 (lot # 657143/0380U). Subsequently, the patient developed erythema at the injection site within one day. The erythema was described as swollen, painful and warm from the injection site to elbow. The pain and swelling prevented the patient from using her arm. Unspecified medical attention was sought.
1/2 hour after receiving vaccine pt. returned to clinic with swelling of hands bilat. and erythematous rash without hives over both arms. No wheezing, but O2 sats dropped to 90% with decreased air movement to lungs. BENADRYL 25 mg given, O2 via trach 6 liters. Stabilized and sent to ER for observation.
07/01/2020 Office Visit notes: History of Present Illness: The patient presents for Rash.  This episode began 1 day ago.  The patient describes the affected area(s) as itchy, red and hives.  Associated symptoms include erythema (skin) and pruritus.  Additional information: Hives an itching started yesterday approximately 4 hours after his first Hep A vaccine.  He denies any other changes.  Patient reports hives were worse yesterday, has been taking Benadryl. Review of Systems: Integumentary: Erythema, Pruritus, Hives Physical Exam: Skin: Hives scattered on body worse on the left side than on right. Assessment/Plan: Hives.  Allergic reaction, initial encounter.  Today we gave you Solu-Medrol (125 mg given IM x1) to help with the hives and itching and to reduce inflammation in your body.  Continue to take Benadryl every 4-6 hours as needed.
It appeared to be a flu or cold. I went on Monday 22nd and the doctor could hear my lungs rattling. They send me to get a chest x ray, there was nothing remarkable, but they notice I had bronchitis.  They gave me a prescription of Methotrexate 4mgs doze pack.  I stop taking it as of last Friday. It's a 6-day regime.
I received the dose on March 12. On March 16 I got sick, throwing up and head ache. Since then I have had     no energy with a slight head ache. My right knee has arthritis and I get cortisone shots. However that knee started really hurting after the vaccination.
Severe reaction to the vaccination; More than one nose bleed; Developed swelling under jaw line; Swelling under neck felt like it was on fire; Felt like I had something under one arm; Too sick to do anything; Short of breath; Immediately became freezing; Developed a horrible headache; Very tired; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Severe reaction to the vaccination), EPISTAXIS (More than one nose bleed), SWELLING FACE (Developed swelling under jaw line), SWELLING (Swelling under neck felt like it was on fire) and LIMB DISCOMFORT (Felt like I had something under one arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Never officially tested. ) in July 2020. Previously administered products included for an unreported indication: FLU VACCINE VII (has it every year). Concomitant products included BUDESONIDE for Allergy, ESTRADIOL for Hormone therapy, LEVOTHYROXINE for Hypothyroidism, CETIRIZINE HYDROCHLORIDE (ZYRTEC R).    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced VACCINATION SITE REACTION (Severe reaction to the vaccination), EPISTAXIS (More than one nose bleed), SWELLING FACE (Developed swelling under jaw line), SWELLING (Swelling under neck felt like it was on fire), LIMB DISCOMFORT (Felt like I had something under one arm), ILLNESS (Too sick to do anything), DYSPNOEA (Short of breath), CHILLS (Immediately became freezing), HEADACHE (Developed a horrible headache), FATIGUE (Very tired) and ARTHRALGIA (Joint pain). At the time of the report, VACCINATION SITE REACTION (Severe reaction to the vaccination), EPISTAXIS (More than one nose bleed), SWELLING FACE (Developed swelling under jaw line), SWELLING (Swelling under neck felt like it was on fire), LIMB DISCOMFORT (Felt like I had something under one arm), ILLNESS (Too sick to do anything), DYSPNOEA (Short of breath), CHILLS (Immediately became freezing), FATIGUE (Very tired) and ARTHRALGIA (Joint pain) was resolving and HEADACHE (Developed a horrible headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included caffeine and paracetamol for headache.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be exclude.   Reporter did not allow further contact; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be exclude.
side effects; she had health problems and she was almost bed ridden; This is a spontaneous report from a contactable consumer. A female patient (one girl) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that for the patient, that it took her 5 to 7 days for the side effects but she got wiped out but she had health problems and she was almost bed ridden. The outcome of the event was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
LOSS OF SMELL; LOSS OF TASTE; LOSS OF APPETITE; CRAMPING ON RIGHT  CALF/SPASMS FOR FEW HOURS; SHOOTING PAIN IN  RIGHT HIP; SHORTNESS OF BREATH; CHILLS; BODY ACHES; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a 35 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fatigue. On 09-APR-2021, the subject experienced chills. On 11-APR-2021, the subject experienced shortness of breath. On an unspecified date, the subject experienced loss of smell, loss of taste, loss of appetite, cramping on right calf/spasms for few hours, and shooting pain in right hip. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, shortness of breath, shooting pain in right hip, loss of appetite, loss of smell, loss of taste, and cramping on right calf/spasms for few hours, and the outcome of fatigue, chills and body aches was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious
DEATH; This spontaneous report received from a consumer via a company representative via social media concerned a male of unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin and batch number were not reported, expiry: unknown) dose, start therapy date were not reported, 1 total, administered for covid-19 prophylaxis. The batch number was not reported. Per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient died from unknown cause of death. It was reported that "we had a very good friend taken the JnJ shot. Now he's dead from it". It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20220933313- covid-19 vaccine ad26. cov2. s- death. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
The student received both his vaccines (covid-19 & influenza), and promptly fainted. His head relaxed backwards, yet he remained upright in the chair. He did not fall out of the chair, and remained seated upright the entire time.  I noted no skin color change, but a loss of consciousness for 15 seconds.  He regained consciousness and was verbal. I checked his pulse and felt a radial pulse, while he regained consciousness. He continued breathing and I noted his chest rising and falling.  I had RN take vital signs and that is what was charted on this consent.   He was verbal and sat to the side and drank some water. He was alert and verbal and oriented to himself and where he was and what was going on.   We contacted the vice principal, who notified the parents and let them know what had happened, but that he was fine. He returned to class with no further incidents while we were on site.
First dose on 16-Mar-21 and second dose on 21-Apr-21; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 16-Mar-21 and second dose on 21-Apr-21) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product INFLUENZA VACCINE INACT SPLIT 4V (FLUARIX QUADRIVALENT) for an unknown indication.    Concurrent medical conditions included Immunocompromised, Psoriatic arthritis, Kidney atrophic, Hepatitis C, Premature ovarian failure, Elevated liver enzymes, Osteoporosis, Insomnia, Depression and Psoriasis. Concomitant products included SERTRALINE for Depression, MIRTAZAPINE for Insomnia, ALENDRONATE SODIUM (ALENDRONATE) for Osteoporosis, DUPILUMAB for Psoriasis, CELECOXIB (CELEBREX) for Psoriatic arthritis.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient received first dose of INFLUENZA VACCINE INACT SPLIT 4V (FLUARIX QUADRIVALENT) (Intramuscular) 1 dosage form. On 21-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 16-Mar-21 and second dose on 21-Apr-21). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 16-Mar-21 and second dose on 21-Apr-21) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient weight was reported as 13 pounds.  Patient had no allergies to medications, food and other products. Patient had no acute illnesses at the time of vaccination and up to one month before.  No treatment medication was provided.   This case was linked to MOD-2022-496302 (Patient Link).
husband in military vaccinated on Friday, February 28.  Patient slept with husband (hedid not have a dressing on), and developed nasal and ulcer, crusts, itching, pain on 3/5.  See by Dr.  (ID specialist) on 3/6.  treated symptomatically and is being followed daily.
Shoulder pain- has persisted, has not resolved  severe headache, nausea, fever
A few days after, a painful rash appeared near the injection site, below the site, in the elbow joint and upper left shoulder blade area.
vaso vagal reaction. client lowered to floor when apparent he was having the reaction. Legs elevated.  Head not hit. Sternal rub x 3 times during first minute to keep him awake. Each time he would say, "I'm OK, I'm OK".  BP monitor brought to room by, RN. BP taken at 11:18 106/74 pulse 63.  client now alert. BP at 11:24 106/69, pulse 85.  BP at 11:31 103/63, pulse 85. Client stands and walks well to waiting room at 11:35.  Leaves clinic at 11:45 with no further problems.  Stated he had not eaten anything for breakfast. Crackers given.
pt states has had pain & swelling of lt arm for last 4 or 5 days;pt states no feeling in lt arm & fingers are tingling & numb;began taking extra strength APAP several times a day for discomfort but it doesn't really relieve pain;
I had a runny nose, cough, sore throat, cough, watery eyes. I took a home COVID-19 test that came back positive, called my doctor's office. I spoke to his nurse to describe my symptoms and let them know I had tested positive for COVID-19. She let the doctor know my symptoms and positive test results. My doctor called in a prescription of the Paxlovid that I was able to start in on Wednesday. By Friday I was able to participate in a work conference by Zoom. I still have a little bit of a cough and stuffy nose but for the most part I am recovered.
13 x 10 cm patch of erythema, localized tenderness, chills, malaise - Right arm.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 55-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received in late November). On 9th February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In February 2019, 10 hrs after receiving SHINGRIX, the patient experienced influenza-like symptoms, general body pain, fever, fatigue, movements reduced, injection site erythema, injection site pain and vein disorder. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the influenza-like symptoms, general body pain, fever, fatigue, movements reduced and vein disorder were recovered/resolved and the outcome of the injection site erythema and injection site pain were not recovered/not resolved. It was unknown if the reporter considered the influenza-like symptoms, general body pain, fever, fatigue, movements reduced, injection site erythema, injection site pain and vein disorder to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX at around 2:00 pm. The patient reported having the same symptoms as with the 1st dose but they were even more severe. They started approximately 10 hours after the 2nd dose and he was incapacitated all day Sunday. On 11th February 2019, 1 day 10 hrs. after receiving 2nd dose, the patient was feeling better but the veins in his right hand were bulging. Also, the injection site on his right arm was red and sore. The patient reports that the sharp pain in his left eye that occurred due to adult onset of Chickenpox and Shingles 5 years ago, has almost totally resolved since receiving the first dose of the SHINGRIX vaccine. The patient would feel the pain in his eye 15 to 25 times a day. At the time of reporting the patient goes days without feeling it and may have it 1 to 2 times in a day if it occurs. The reporter did not give consent to follow up. This case has been linked to the US2019025000, reported for the dose 2 of the same patient.
pt recvd vax 12JUl93 & admitted to hosp 13JUL93 w/sz & temp of 105;
Information has been received from an 80 year old male consumer with degenerative neurological problems diagnosed three years ago and gemfibrozil allergy who on 06-MAR-2008 was vaccinated with a single dose of series of zoster vaccine live (Oka/Merck). Concomitant therapy included fish oil, aspirin, vitamins (unspecified), lisinopril, FELODIPIN and NITRO which he stated he does not use. Subsequently, around 10-MAR-2008 the patient started to get dizzy, have a headache and vertigo to the point where when he got up from his chair he could not tell if he was standing upright and fell over. The patient stated he fell the other day. Medical attention was sought, there were no lab studies performed. The patient stated he went to see his family physician. The family physician told him to get a MRI and a "cat scan" to see what is going on with his head. The patient stated he has not gotten the MRI or "cat scan" as of yet. At the time of the report the patient stated the experiences he is having are reoccurring and have not gone away yet. There was no product quality complaint involved. Follow-up information from the physician's office indicated the patient the patient ended up having a subdural hematoma from a fall that happened on an unspecified date before the vaccination. He has had surgery. No further information was provided. Follow-up information from the physician's office indicated that the subdural hematoma did not come from the zoster vaccine live (Oka/Merck) vaccination. It came from a fall prior to receiving the vaccination. Additional information is not expected.
Internal bruising; Had first dose vaccination and in the same arm had swelling in upper arm muscle tissue; Vaccination area was getting worst; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm on 20May2021 (Batch/Lot Number: EW0176) as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that the patient had first Covid vaccine shot on 20May2021 and second shot (dose) vaccine has been scheduled on 10Jun2021. Since the patient had the first dose vaccination, in the same arm the patient had a very bad swelling in upper arm muscle tissue and vaccination area was getting worst. The patient was also having internal bruising. The patient was trying to find out if this was something normal reaction or do the patient need to go and see an Emergency care Physician right away. Outcome of the events was unknown.
Severe headaches; dizziness; blurry vision; weak unable to do anything; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 12Jul2021 12:15 (Batch/Lot number: unknown) at the age of 45 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "penicillin" (unspecified if ongoing), notes: known allergies: Codine and penicillin. There were no concomitant medications. Past drug history included: Codine, reaction(s): "Known allergies: Codine", notes: Known allergies: Codine and penicillin. Vaccination history included: Bnt162b2 (lot unknown: True, lot unknown reason: Other, administration date: 21Jun2021, administration time: 12:30 PM, dose number: 1, vaccine location: Right arm), administration date: 21Jun2021, when the patient was 45 years old, for COVID-19 Immunisation. The following information was reported: HEADACHE (non-serious) with onset 13Jul2021 19:00, outcome "not recovered", described as "Severe headaches"; DIZZINESS (non-serious) with onset 13Jul2021 19:00, outcome "not recovered", described as "dizziness"; VISION BLURRED (non-serious) with onset 13Jul2021 19:00, outcome "not recovered", described as "blurry vision"; ASTHENIA (non-serious) with onset 13Jul2021 19:00, outcome "not recovered", described as "weak unable to do anything". The events "severe headaches", "dizziness", "blurry vision" and "weak unable to do anything" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were not taken as a result of headache, dizziness, vision blurred, asthenia.  Additional information: Facility type vaccine was pharmacy or Drug Store. No other vaccine in four weeks. No covid prior vaccination and covid tested post vaccination.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Patient said his symptoms were the same as what he had with the COVID vaccine (body aches, soreness, redness at injection)
unexplained burning on forearms, hands, feet, ankles;pain in ankles;twitching in legs & feet;anxiety, sweats & flushing;pulse skips;unexplained fluctuation in BP to date;tx Lopresser, Klonopin, doxeyeline;refer to physician
About 2 weeks after the vaccine, I started having difficulty breathing and shortness of breath.  I called my PCP who prescribed me Albuterol nebulizer 4 times a day.  I was still having difficulty breathing so my PCP was going to order a chest x-ray.  My symptoms were so bad I just decided to go to the ER.  At the ER, they did blood work and chest x-ray and found fluid in my lungs.  I was admitted to the hospital and stayed 6 days.  I was hooked up to an EKG and given an IV.  A cardiologist consulted with me and diagnosed me with A-fib.  I was discharged with new medications, a portable defibrillator and to follow up with a cardiologist.  I followed up with cardiologist who had to shock me 2 times to get me back into normal rhythm.   I have reoccuring A-fib and will follow up with cardiologist for my plan of care.
Itchy, red, raised circular rash around injection site that occurred 3 days after injection. The rash was approximately 3-4 inches around. One dose of benadryl was taken. Rash disappeared within 24 hrs.
a little soreness at the injection site which migrated to his back and upper shoulder and to the; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (a little soreness at the injection site which migrated to his back and upper shoulder and to the) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included POTASSIUM, FAMOTIDINE, LOSARTAN, DOXAZOSIN, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HYDROCHLOROTHIAZIDE) and CLONIDINE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN (a little soreness at the injection site which migrated to his back and upper shoulder and to the). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (a little soreness at the injection site which migrated to his back and upper shoulder and to the) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Pt. came into clinic for annual flu shot. Was non-ill appearing. Wife received same flu shot at the same time with no adverse rxn. Pt. then went home and later passed away in house (residence).